Poster Presentation 1

[PP1-01] The impact of the number of neoadjuvant chemotherapy cycles on prognosis after radical cystectomy

*Shingo Hatakeyama¹, Rikiya Taoka², Jun Miki^3,4, Ryoichi Saito⁵, Wataru Fukuokaya^3,4, Yoshiyuki Matsui⁶, Takashi Kawahara⁷, Ayumu Matsuda⁶, Taketo Kawai^8,9, Minoru Kato¹⁰, Tomokazu Sazuka¹¹, Takeshi Sano¹², Fumihiko Urabe^4,13, Soki Kashima¹⁴, Hirohito Naito¹⁵, Yoji Murakami¹⁶, Naotaka Nishiyama¹⁷, Hiroyuki Nishiyama⁷, Hiroshi Kitamura¹⁷, Chika Ohyama¹ (1. Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan, 2. Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan, 3. Department of Urology, Jikei University Kashiwa Hospital, Chiba, Japan, 4. Department of Urology, The Jikei University School of Medicine, Japan, 5. Department of Urology and Andrology, Kansai Medical University, Osaka, Japan, 6. Department of Urology, National Cancer Center Hospital, Tokyo, Japan, 7. Department of Urology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 8. Department of Urology, Graduate School of Medicine, The University of Tokyo, Japan, 9. Department of Urology, Teikyo University School of Medicine, Tokyo, Japan, 10. Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan, 11. Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan, 12. Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 13. Department of Urology, Jikei University Hospital, Tokyo, Japan, 14. Department of Urology, Akita University Graduate School of Medicine, Akita, Japan, 15. Department of Urology, Kurashiki Central Hospital, Okayama, Japan, 16. Department of Urology, Graduate School of Life Science, Kumamoto University, Kumamoto, Japan, 17. Department of Urology, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan)